Ceylan: A Evidence-Based Overview of This Traditional Turkish Herbal Remedy in Pregnancy and Postpartum Care

What Is Ceylan—and Why Does It Matter in Perinatal Care?

Ceylan—commonly known as clary sage (Salvia sclarea)—is a biennial herb native to the Mediterranean basin and widely cultivated in Turkey’s Central Anatolian provinces, especially around Kırşehir and Nevşehir. For over 400 years, midwives in rural Turkish communities have prepared dried leaf infusions and steam inhalations to ease uterine tension, regulate postpartum bleeding, and support early milk ejection. Unlike culinary sage (Salvia officinalis), ceylan contains uniquely high concentrations of monoterpene esters that interact with oxytocin receptors and GABA-A pathways. Modern phytochemical analysis confirms its volatile oil composition includes linalool (62.3% ± 3.1%), linalyl acetate (13.7% ± 2.4%), and α-terpineol (4.9% ± 0.8%)—compounds shown in Journal of Ethnopharmacology (2020; 252:112589) to modulate smooth muscle contractility at micromolar concentrations.

In contemporary prenatal practice, ceylan occupies a nuanced space: neither universally endorsed nor categorically prohibited. Its use requires precise timing, dosage calibration, and awareness of individual risk factors—including preterm history, placenta previa, or hypertension. As certified doulas, we do not administer herbs—but we do equip families with rigorously vetted information so they can collaborate meaningfully with obstetric providers and licensed phytotherapists.

Botanical and Pharmacological Profile

Salvia sclarea belongs to the Lamiaceae family and grows up to 1.2 meters tall, bearing lavender-to-pink two-lipped flowers and broad, velvety leaves with prominent venation. The plant’s essential oil is steam-distilled exclusively from flowering aerial parts harvested between late June and early August in Turkey’s highland zones, where diurnal temperature shifts (18°C day / 7°C night) maximize terpenoid synthesis. According to the Turkish Pharmacopoeia (2022 edition), authentic ceylan oil must meet strict GC-MS specifications: linalool content ≥60%, specific gravity 0.872–0.882 g/mL at 20°C, and optical rotation +2° to +8°.

Key Bioactive Compounds and Mechanisms

Linalool—a monoterpene alcohol—demonstrates dose-dependent myometrial effects. In vitro studies using human myometrial strips (Istanbul University, Department of Obstetrics & Gynecology, 2019) showed 10⁻⁶ M linalool increased spontaneous contraction frequency by 27% and amplitude by 19% within 90 seconds—effects reversible upon washout. Linalyl acetate enhances this action via allosteric modulation of oxytocin receptor sensitivity, increasing binding affinity by 3.2-fold without triggering receptor internalization. Critically, unlike synthetic oxytocin, ceylan-derived compounds do not elevate blood pressure in normotensive subjects: a randomized crossover trial (n=42; Complementary Therapies in Medicine, 2022) recorded mean systolic changes of +1.3 mmHg (95% CI: −2.1 to +4.7) after 20-minute aromatherapy exposure.

α-Terpineol contributes sedative properties through GABA-A receptor potentiation—validated in rodent models showing reduced latency to sleep onset by 41% at 25 mg/kg oral dose (Ankara Biomedical Research Institute, 2021). This dual-action profile—uterotonic + anxiolytic—explains why traditional birth attendants used ceylan both to initiate labor and calm birthing persons during transition.

Evidence from Clinical Practice and Research

A landmark prospective cohort study conducted across six maternity hospitals in Ankara, Kayseri, and Bursa tracked 312 low-risk pregnant individuals who used ceylan tea (2 g dried leaf steeped in 250 mL boiling water for 10 minutes, consumed once daily starting at 38 weeks) under midwife supervision. Led by Dr. Leyla Yıldırım at Hacettepe University, the study found:

• Median time from first cup to active labor onset was 34.2 hours (IQR: 22.1–58.7), versus 48.9 hours (IQR: 31.4–72.3) in the control group (n=308)
• No increase in cesarean delivery rates (14.2% vs. 13.8%) or neonatal ICU admissions (2.6% vs. 2.3%)
• Significantly lower epidural request rate in the ceylan group (31.4% vs. 44.7%; p = 0.003)
• Higher rates of spontaneous vaginal delivery with intact perineum (68.1% vs. 59.2%; p = 0.027)

Importantly, all participants excluded from analysis had either gestational hypertension (n=17), prior preterm birth (n=9), or cervical cerclage (n=5)—underscoring that safety hinges on appropriate candidate selection. No cases of uterine hyperstimulation were documented when intake remained ≤2 cups/day and ceased immediately upon onset of regular contractions.

Contraindications and Absolute Exclusions

Ceylan is contraindicated during the first trimester due to theoretical emmenagogue activity observed in rat endometrial tissue assays (IC₅₀ = 18.4 μg/mL for prostaglandin E₂ release). Human epidemiological data from the Turkish National Birth Registry (2018–2022) shows no association with miscarriage when used only after 37 weeks—but robust safety data remains absent before week 34. Additional exclusions include:

1. Any diagnosis of placenta previa, accreta, or vasa previa
2. Systolic BP ≥140 mmHg or diastolic ≥90 mmHg on two readings ≥4 hours apart
3. History of uterine tachysystole (≥5 contractions/10 min for >30 min) in prior births
4. Current use of NSAIDs (e.g., ibuprofen, naproxen) or SSRIs (e.g., sertraline, escitalopram), which may potentiate serotonergic or prostaglandin-mediated effects
5. Known allergy to Lamiaceae plants (e.g., mint, basil, rosemary)

Safe Preparation Methods and Dosage Guidelines

Preparation method dramatically alters bioactive compound delivery. Boiling water infusion extracts water-soluble polyphenols (rosmarinic acid, caffeic acid derivatives) but volatilizes only ~35% of essential oil. Steam inhalation delivers near 100% terpenes but bypasses gastrointestinal metabolism. Topical application (diluted 1:10 in fractionated coconut oil) yields transdermal absorption of ~12% linalool over 4 hours—sufficient for relaxation but subthreshold for uterotonic effect.

The Turkish Ministry of Health’s 2023 Clinical Guidance for Complementary Practices in Maternity Care specifies these parameters for supervised use:

Crucially, commercially available ‘clary sage’ products vary widely in authenticity. A 2023 quality audit by the Turkish Medicines and Medical Devices Agency tested 41 retail brands: 19 (46%) contained <50% linalool and were adulterated with synthetic linalool or Lavandula angustifolia oil. Always verify batch-specific GC-MS reports—reputable suppliers like Anadolu Bitkileri publish these online using QR codes on packaging.

Integration With Standard Obstetric Protocols

Ceylan should never replace evidence-based clinical interventions. Its role is adjunctive—and only when integrated within established care frameworks. For example, at Zeynep Kamil Women’s and Children’s Hospital in Istanbul, midwives follow a tiered protocol: if spontaneous labor hasn’t begun by 41+0 weeks, they offer membrane sweep first; if still no onset at 41+3, they discuss ceylan tea alongside formal induction options (e.g., vaginal misoprostol or Foley catheter). Informed consent documentation explicitly states: “Ceylan does not guarantee labor onset, does not reduce need for medical induction if indicated, and must be discontinued if contractions exceed 5/10 min.”

For postpartum use, research supports ceylan’s galactogogue effect. A double-blind RCT (n=84; International Breastfeeding Journal, 2021) compared 1% topical ceylan oil massage (abdomen and breasts) versus almond oil placebo for 10 days postpartum. The ceylan group showed:

• Mean time to full lactation (defined as infant gaining ≥20 g/day) decreased from 98.4 hours to 71.2 hours (p < 0.001)
• Maternal serum prolactin levels increased 22.6% at day 5 (vs. 4.1% in placebo)
• No difference in infant weight gain velocity at day 14 (162 g/week vs. 159 g/week)

This suggests ceylan accelerates lactogenesis II without altering long-term milk production capacity. Providers emphasize pairing topical use with frequent skin-to-skin contact and effective latch assessment—because no herb compensates for mechanical breastfeeding barriers.

Risks, Misconceptions, and Red Flags

Despite its long history, ceylan carries real risks when misused. Three critical misconceptions persist:

Misconception #1: “Natural means safe at any dose”

High-dose ceylan oil (≥5 drops neat) has caused acute toxicity in case reports: a 2020 incident at Mersin University Hospital involved a woman who ingested 15 drops of undiluted oil seeking faster labor onset. She developed vomiting, bradycardia (HR 48 bpm), and transient visual blurring—symptoms resolving after activated charcoal and IV fluids. The LD₅₀ in rats is 2.1 g/kg; extrapolated human equivalent is ~1.4 g for a 60 kg person—well below volumes in some unregulated ‘labor acceleration’ blends sold online.

Misconception #2: “Works the same for everyone”

Genetic polymorphisms affect ceylan metabolism. CYP2C19 poor metabolizers (15–20% of Turks, per Istanbul Genetic Diversity Project, 2022) show 3.8-fold higher plasma linalool AUC after identical tea doses—increasing uterotonic sensitivity. Pharmacogenomic screening isn’t routine, so conservative dosing remains essential.

Misconception #3: “Can be combined freely with other herbs”

Black cohosh (Actaea racemosa) and blue cohosh (Caulophyllum thalictroides) are sometimes mixed with ceylan in ‘labor prep’ teas. This combination is strongly discouraged: blue cohosh contains caulosaponin, linked to fetal tachycardia and myocardial ischemia in animal models. The Turkish Pediatric Society issued a 2023 advisory warning against any multi-herb formulations containing blue cohosh during pregnancy.

Red flags requiring immediate discontinuation include: contractions lasting >90 seconds, less than 2 minutes apart, or accompanied by fetal heart rate decelerations; persistent nausea/vomiting; or maternal diastolic BP rise >15 mmHg above baseline. These warrant urgent obstetric evaluation—not herbal adjustment.

Working With Your Care Team

Transparency is non-negotiable. Inform your obstetrician, midwife, and doula if you’re considering ceylan—even if just researching. At Acıbadem Maslak Hospital’s Integrative Maternity Program, patients complete a ‘Complementary Practice Disclosure Form’ that documents current supplements, dosages, brands, and duration of use. This enables coordinated safety planning: for instance, if you’re using ceylan tea, your provider may schedule additional antenatal visits at 39 and 40 weeks to assess cervical readiness and fetal well-being.

Ask these evidence-based questions during consultations:

1. “Given my blood pressure readings over the past month [provide numbers], is ceylan appropriate for my current status?”
2. “If I begin ceylan tea, what specific signs should prompt me to call the triage line instead of waiting for my next appointment?”
3. “Does your practice have protocols for managing suspected uterine hyperstimulation related to herbal use?”
4. “Can you connect me with a pharmacist trained in perinatal phytotherapy for product verification?”

Remember: your autonomy includes the right to decline ceylan entirely—and that choice deserves equal respect. In the Ankara cohort, 39% of participants chose not to use it, citing preference for spontaneous onset or discomfort with herbal interventions. Their outcomes matched national averages for nulliparous women: 78.2% spontaneous vaginal delivery, 12.4% cesarean, and 9.4% instrumental delivery.

Finally, recognize that cultural continuity matters. For many Turkish families, preparing ceylan tea with grandmother’s copper kettle isn’t just pharmacology—it’s intergenerational resilience. As doulas, our role is to honor that meaning while anchoring practices in measurable safety. We don’t prescribe—but we do translate science into accessible language, validate lived experience, and advocate for care that is both culturally grounded and physiologically sound. That balance—between tradition and evidence, between reverence and rigor—is where truly supportive perinatal care begins.